Morré D J, Jacobs E, Sweeting M, de Cabo R, Morré D M
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.
Biochim Biophys Acta. 1997 Apr 3;1325(1):117-25. doi: 10.1016/s0005-2736(96)00250-7.
Plasma membrane vesicles isolated from HeLa cells grown in suspension culture contain a protein disulfide-thiol interchange (protein disulfide-like) activity. The activity was estimated from the restoration of activity to inactive (scrambled) pancreatic RNAase. RNAase activity was measured either by hydrolysis of cCMP or by a decrease in acid precipitable yeast RNA. The ability of plasma membrane vesicles to restore activity to inactive (scrambled) pancreatic ribonuclease was inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984). The activity correlated with that of a cyanide-resistant NADH oxidase also associated with the plasma membrane vesicles that exhibited a similar pattern of drug response. The activity was stimulated by reduced glutathione and inhibited by oxidized glutathione but did not depend on either for activity. The antitumor sulfonylurea-inhibited activity was greatest in the presence of reduced glutathione and least in the presence of oxidized glutathione. The antitumor sulfonylurea-inhibited activity was unaffected by a monoclonal antibody to protein disulfide isomerase. Also the antitumor sulfonylurea-inhibited activity was unaffected by peptide antisera to the consensus active site sequence of protein disulfide isomerase. Thus the antitumor sulfonylurea-inhibited activity appeared to reside with a novel cell surface protein capable of oxidation of both NADH and protein thiols and of carrying out a protein disulfide isomerase-like protein disulfide-thiol interchange activity in the absence of NADH or other external reductants.
从悬浮培养的HeLa细胞中分离出的质膜囊泡含有一种蛋白质二硫键-硫醇交换(类蛋白质二硫键)活性。该活性通过将无活性(混乱的)胰腺核糖核酸酶的活性恢复来估算。核糖核酸酶活性通过cCMP的水解或酸性可沉淀酵母RNA的减少来测量。质膜囊泡将无活性(混乱的)胰腺核糖核酸酶恢复活性的能力受到抗肿瘤磺酰脲N-(4-甲基苯磺酰基)-N'-(4-氯苯基)脲(LY181984)的抑制。该活性与一种抗氰化物的NADH氧化酶的活性相关,该氧化酶也与质膜囊泡相关,且表现出相似的药物反应模式。该活性受到还原型谷胱甘肽的刺激,被氧化型谷胱甘肽抑制,但活性并不依赖于两者中的任何一种。抗肿瘤磺酰脲抑制的活性在还原型谷胱甘肽存在时最大,在氧化型谷胱甘肽存在时最小。抗肿瘤磺酰脲抑制的活性不受蛋白质二硫键异构酶单克隆抗体的影响。同样,抗肿瘤磺酰脲抑制的活性也不受针对蛋白质二硫键异构酶共有活性位点序列的肽抗血清的影响。因此,抗肿瘤磺酰脲抑制的活性似乎存在于一种新型细胞表面蛋白中,该蛋白能够氧化NADH和蛋白质硫醇,并且在没有NADH或其他外部还原剂的情况下能够进行类似蛋白质二硫键异构酶的蛋白质二硫键-硫醇交换活性。